It never stops, does it, the stories of the crooked pharmaceutical industry.
A pharmaceutical company has broken competition law by “charging excessive and unfair prices”. Actavis raised prices for 10mg hydrocortisone tablets from 79p in April 2008 to £88 per pack by March 2016. Actavis also increased the price of 20mg hydrocortisone tablets by nearly 9,500 per cent compared to the previous branded price, equating to charges to the NHS of £102.74 per pack by March 2016, when it had previously paid £1.07 for the branded drug.
This means between 2008 and 2015, the NHS's spend on the drug rose from £522,000 to £70 million.